--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.736B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 828.840
- -14.760-1.75%
Close Nov 4 16:00 ET
91.08BMarket Cap20.50P/E (TTM)
852.010High826.760Low743.69KVolume845.590Open843.600Pre Close621.90MTurnover0.70%Turnover Ratio23.84P/E (Static)109.89MShares1211.20052wk High3.11P/B87.65BFloat Cap784.95952wk Low--Dividend TTM105.75MShs Float1211.200Historical High--Div YieldTTM2.99%Amplitude4.610Historical Low836.230Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Regeneron Pharmaceuticals Q3 2024 Earnings Date
Currency：USDOct 31, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 3.67B | 3.72B | +53.88M |
| Beat Est. | +9.04% | +10.65% | +1.47% |
| EPS | 9.75 | 11.54 | +1.79 |
| Beat Est. | +9.64% | +29.81% | +18.39% |
Analyst Rating
Nov 5, 2024
Regeneron Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Regeneron Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
